Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
November 2010
Features
Letters to the Editor
Health Care and Law
Antipsychotic Medications Are Spelling Legal Trouble for Drugmakers
Makers of atypical antipsychotic medications are under scrutiny for promoting the off-label use of these agents, a practice that has led to serious adverse events and has cost the manufacturers billions of dollars in penalties.
Robert I. Field, JD, MPH, PhD
Personalized Medicine
Part 2: Ethical, Legal, and Regulatory Issues
The health care reform bill, privacy rules, health information technology, genetic testing, and a trend toward collaboration among federal agencies indicate that all stakeholders will have to change their business practices in the future.
F. Randy Vogenberg, PhD, RPh; Carol Isaacson Barash, PhD; and Michael Pursel, RPh, MBA
Commentary
Health Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals
With the passage of the Patient Protection and Affordable Care Act, five new categories of hospitals and clinics will be able to buy many drugs at reduced prices.
Stephen Barlas
Meeting Highlights
Transcatheter Cardiovascular Therapeutics Conference 2010 and Second World Parkinson Congress
Sessions of the cardiovascular conference addressed the effect of statins on myocardial infarction, the safety of atopaxar (E5555) in acute coronary syndromes, and a comparison of clopidogrel (Plavix) and Prasugrel (Effient). The Parkinson meeting featured gastrointestinal absorption and the value of paroxetine (Paxil), venlafaxine (Effexor), and ritigotine (Neupro) in patients’ quality of life.
Walter Alexander
Pharmaceutical Approval Update
Topics include fingolimod capsules (Gilenya) for patients with relapsing multiple sclerosis; pegloticase (Krystexxa), an injectable product for gout; and Beyaz, a formulation of Yaz, an oral contraceptive that includes a folate vitamin to reduce the risk of neural tube defects.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Target Quality
Thomas Jefferson University Hospital is working to reduce adverse events by using anticoagulation management, a pharmacy service line approach, and technology to enhance patient safety.
David B. Nash, MD, MBA
Medication Errors
Remote Computerized Prescriber Entry Errors—More Than 'Remotely' Possible
Mistakes in prescribing, dispensing, and administering drugs are more likely when the agent is ordered from a remote location and when procedures are not reviewed.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
The Avenue to Discounts for Non-Profit Hospital Pharmacies
Meeting the Requirements of the Non-Profit Institutions Act
Changes in the government’s drug pricing program, along with the Non-Profit Institutions Act exemption, may enable hospital pharmacies to buy drugs at a lower cost.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, new drug indications, and updates
Drug Forecast
Estradiol Valerate and Estradiol Valerate/Dienogest (Natazia) Tablets
The First Four-Phasic Oral Contraceptive
Natazia, a four-phasic oral contraceptive
Uche Anadu Ndefo, PharmD, BCPS; and Nina Mosely, PharmD Candidate
